Related Experiment Video
Updated: Apr 17, 2026

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids
Published on: May 16, 2025
Plasmid DNA-coding p62 as a bone effective anti-inflammatory/anabolic agent.
Maria Giovanna Sabbieti1, Dimitrios Agas1, Melania Capitani1
1School of Biosciences and Veterinary Medicine, University of Camerino, Camerino (Italy).
p62 DNA plasmid unexpectedly treats osteoporosis by reducing inflammation and boosting bone formation. This novel DNA vaccine shows promise for inflammatory bone loss diseases.
Area of Science:
- Immunology
- Molecular Biology
- Bone Biology
Background:
- p62-SQSTM1 DNA plasmid previously showed anti-tumor vaccine efficacy.
- Osteoporosis is a significant health concern, particularly inflammatory bone loss.
Purpose of the Study:
- To investigate the unexpected anti-osteoporotic effects of p62 DNA.
- To elucidate the mechanisms behind p62 DNA's impact on bone loss.
Main Methods:
- Utilized a mouse model of inflammatory bone loss induced by ovariectomy.
- Administered p62 DNA via intramuscular delivery.
- Analyzed inflammatory cytokine levels and endogenous p62 protein expression in bone-marrow stromal cells.
Main Results:
- p62 DNA demonstrated potent anti-osteoporotic activity, exhibiting bone-sparing and osteo-synthetic effects.
- Suppression of osteoporosis correlated with down-regulation of key inflammatory cytokines.
- Observed up-regulation of endogenous p62 protein in bone-marrow stromal cells.
Conclusions:
- p62 DNA therapy offers a novel therapeutic strategy for inflammatory bone loss diseases.
- The anti-osteoporotic effects are mediated by reduced inflammation and enhanced bone formation.
- Further research supports p62 DNA vaccine as a safe treatment for osteoporosis.
More Related Videos
07:53Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
Published on: December 10, 2010
11:20Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
Published on: March 29, 2018
Related Concept Videos
Abnormal Proliferation
Plasmids
Stringent Response in E. coli